Jennifer Amsler

Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study

Matthias B. Moor, Franziska Suter‐Riniker, Michael P. Horn et al. · The Lancet Rheumatology · 2021 · 211 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept study

Lisa Christ, Luca Seitz, Godehard Scholz et al. · The Lancet Rheumatology · 2021 · 67 citations

Pharmacy, Pharmacotherapy, Immunotherapy +14

CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival

Viktor H. Koelzer, Alessandro Lugli, Heather Dawson et al. · Journal of Translational Medicine · 2014 · 63 citations · Full text

Medicine, Oncology, Pathology +17

Vision loss in patients with giant cell arteritis treated with tocilizumab

Jennifer Amsler, Iveta Kysela, Christoph Tappeiner et al. · Arthritis Research & Therapy · 2021 · 25 citations · Full text

Medicine, Ophthalmology, Ocular Disease +9

Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy

Daniel Sidler, Alexander Born, Simeon Schietzel et al. · RMD Open · 2022 · 19 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17